Genetic Engineering — Revision Notes

⚡ 30-Second Revision

Genetic Engineering: Direct DNA manipulation.
Key Techniques: Recombinant DNA, Gene Editing (CRISPR-Cas9, Base Editing, Prime Editing), Gene Therapy.
CRISPR-Cas9: Guide RNA + Cas9 enzyme = precise DNA cuts.
GMOs: Genetically Modified Organisms (e.g., Bt cotton, Golden Rice).
Gene Therapy: Correcting faulty genes (somatic vs. germline).
Indian Regulator: GEAC (Genetic Engineering Appraisal Committee) under MoEFCC.
Constitutional Links: Article 21 (Right to Life), Article 48A (Environment), Article 51A(h) (Scientific Temper).
International: Cartagena Protocol on Biosafety (LMOs).
Ethics: Germline editing, equity, dual-use risks.
Recent: Differentiated regulation for gene-edited crops (SDN-1/2) in India; CRISPR in clinical trials for genetic diseases; mRNA vaccines.

2-Minute Revision

Genetic engineering involves the deliberate alteration of an organism's genetic material. It began with recombinant DNA (rDNA) technology, which allows combining DNA from different sources. Modern advancements include precise gene-editing tools like CRISPR-Cas9, which uses a guide RNA and Cas9 enzyme to make targeted DNA cuts, enabling gene knockout, insertion, or correction.

These techniques are applied across various sectors. In agriculture, they produce Genetically Modified Organisms (GMOs) like Bt cotton (pest resistance) and Golden Rice (Vitamin A enrichment), aiming to enhance food security.

In medicine, gene therapy offers cures for genetic disorders by replacing or repairing faulty genes, and genetic engineering was pivotal in developing rapid mRNA and viral vector COVID-19 vaccines. India regulates these technologies through a multi-tier system, with the Genetic Engineering Appraisal Committee (GEAC) being the apex body for environmental release approvals, guided by the Environment (Protection) Act, 1986.

Internationally, the Cartagena Protocol on Biosafety governs the transboundary movement of Living Modified Organisms (LMOs). Ethical concerns, particularly around germline editing, equitable access, and potential environmental impacts, remain central to public and policy debates, necessitating a balanced approach that integrates scientific progress with robust oversight and societal values.

5-Minute Revision

Genetic engineering is the precise manipulation of an organism's DNA, moving beyond traditional breeding to directly alter genetic traits. The field's foundation lies in recombinant DNA (rDNA) technology, which involves isolating a gene, inserting it into a vector (like a plasmid), and introducing this into a host.

The advent of gene-editing tools, notably CRISPR-Cas9, revolutionized this by allowing highly targeted modifications. CRISPR works by using a guide RNA to direct the Cas9 enzyme to a specific DNA sequence, where it makes a double-stranded cut, which can then be repaired by the cell to either disable a gene or insert/correct a new sequence.

More refined techniques like base editing and prime editing offer even greater precision without double-stranded breaks.

Applications are diverse and impactful. In agriculture, genetically modified organisms (GMOs) like Bt cotton (pest resistance) and Golden Rice (Vitamin A enrichment) enhance crop resilience and nutritional value, contributing to food security.

In medicine, gene therapy aims to correct genetic defects causing diseases (e.g., sickle cell anemia), while genetic engineering is crucial for producing biopharmaceuticals (e.g., insulin) and developing advanced vaccines (e.

g., mRNA COVID-19 vaccines). Industrial applications include bioremediation and enzyme production.

India's regulatory framework is robust, established under the Environment (Protection) Act, 1986, and the 1989 Rules. The multi-tier system includes Institutional Biosafety Committees (IBSCs) at the research level, the Review Committee on Genetic Manipulation (RCGM) for research oversight, and the Genetic Engineering Appraisal Committee (GEAC) as the apex body for environmental release and commercialization approvals.

Recent policy changes, such as the 2022 notification differentiating gene-edited crops (SDN-1/2) from traditional GMOs, aim to streamline approvals for less risky modifications. Globally, the Cartagena Protocol on Biosafety governs the transboundary movement of Living Modified Organisms (LMOs), emphasizing biosafety and biodiversity protection.

Ethical considerations are paramount: debates surround germline editing (heritable changes), equitable access to expensive therapies, informed consent, and potential dual-use risks. Constitutional provisions like Article 21 (Right to Life), Article 48A (Environmental Protection), and Article 51A(h) (Scientific Temper) provide the Indian context for these discussions.

Understanding the scientific principles, diverse applications, regulatory landscape, and ethical dimensions is crucial for a comprehensive UPSC preparation.

Prelims Revision Notes

1
Definition — Genetic engineering is direct manipulation of DNA. rDNA technology is foundational. Gene editing (CRISPR-Cas9, Base Editing, Prime Editing) offers precision.
2
CRISPR-Cas9 — Bacterial origin. Components: Guide RNA (targets DNA), Cas9 enzyme (cuts DNA). Mechanism: gRNA guides Cas9 to target, Cas9 cuts, cell repairs (NHEJ for knockout, HDR for insertion/correction).
3
GMOs — Organisms with altered genetic material. Examples: Bt cotton (pest resistance via *Bacillus thuringiensis* gene), Golden Rice (Vitamin A enrichment via beta-carotene gene).
4
Gene Therapy — Treats genetic diseases by modifying genes. Types: Somatic (non-heritable, common), Germline (heritable, controversial). Delivery: Viral (AAV, lentivirus) or non-viral vectors.
5
Regulatory Bodies (India)

* IBSC: Institutional Biosafety Committees (lab level). * RCGM: Review Committee on Genetic Manipulation (research oversight, DBT). * GEAC: Genetic Engineering Appraisal Committee (apex body, MoEFCC; approves environmental release, commercialization). * Governed by Environment (Protection) Act, 1986 & 1989 Rules.

1
Recent Policy — 2022 MoEFCC notification exempted SDN-1/2 gene-edited organisms from stringent GMO rules.
2
International — Cartagena Protocol on Biosafety (under CBD) for safe transboundary movement of LMOs (Living Modified Organisms).
3
Constitutional Links — Article 21 (Right to life/health), Article 48A (Environmental protection), Article 51A(h) (Scientific temper).
4
Ethical Issues — Germline editing, 'designer babies', equitable access, informed consent, dual-use risks, environmental impact.
5
COVID-19 Link — mRNA and viral vector vaccines are products of genetic engineering.

Mains Revision Notes

1
Introduction — Define genetic engineering, highlight its transformative potential and inherent challenges (innovation vs. precaution).
2
Techniques & Applications

* rDNA: Foundation, biopharmaceuticals (insulin). * Gene Editing (CRISPR): Precision, medical (gene therapy for genetic disorders, cancer), agricultural (enhanced traits, climate resilience). * Gene Therapy: Somatic vs. Germline (ethical debate), delivery mechanisms, approved therapies. * GMOs: Food security, reduced pesticide use (Bt cotton), nutritional enhancement (Golden Rice), but also concerns (resistance, biodiversity).

1
Regulatory Framework (India)

* Structure: IBSC -> RCGM -> GEAC. Explain their roles and interlinkages. * Challenges: Scientific uncertainty, public perception, transparency, capacity, political influence, enforcement. * Policy Evolution: 2022 gene-editing rules – rationale for differentiation, potential impact. * Constitutional Angle: Link to Article 21 (health, safe food), Article 48A (environment), Article 51A(h) (scientific temper) – how these guide policy.

1
International Context

* Cartagena Protocol: Objective, AIA procedure, India's role, biodiversity protection. * TRIPS/IPR: Patenting issues, access vs. innovation, monopolization, benefit-sharing. * WHO: Ethical guidance for human gene editing.

1
Ethical & Societal Concerns

* Germline Editing: 'Designer babies', unforeseen effects, human dignity. * Equity & Access: High cost of therapies, global disparities. * Dual-Use: Bioweapons, misuse of technology. * Environmental: Gene flow, superweeds/superpests, biodiversity impact. * Addressing: Robust governance, public dialogue, international cooperation, ethical guidelines.

1
Conclusion — Emphasize the need for responsible innovation, balancing scientific progress with ethical considerations, environmental safety, and equitable societal benefits. Vyyuha Connect: Link to food security, public health, climate adaptation, India's biotech mission.

Vyyuha Quick Recall

CRISPR-GEAC: C - Cartagena Protocol (International Biosafety) R - Recombinant DNA (Foundational technique) I - IPR Issues (Patents, TRIPS) S - Somatic vs. Germline (Gene Therapy types) P - Precision (CRISPR's key advantage) R - Regulatory Framework (India: GEAC, RCGM, IBSC) - G - GMOs (Genetically Modified Organisms) E - Ethical Concerns (Germline editing, equity) A - Applications (Agriculture, Medicine, Industry) C - Constitutional Articles (21, 48A, 51A(h))